VAP-B binds to Rab3GAP1 at the ER: Its implication in nuclear envelope formation through the ER-Golgi intermediate compartment

Kobe Journal of Medical Sciences

Volumn 60, Issue 3, 2014, Pages E48-E56

  Hantan, Degejirihu ^a   Yamamoto, Yasunori ^a   Sakisaka, Toshiaki ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ERGIC; Nuclear envelope; Rab3GAP; VAP B

Indexed keywords

ALANINE; GLUTAMIC ACID; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PHENYLALANINE; PROLINE; RAB PROTEIN; RAB3 GTPASE ACTIVATING PROTEIN 1; SERINE; SYNAPTOBREVIN; SYNAPTOBREVIN B; UNCLASSIFIED DRUG; CARRIER PROTEIN; HYBRID PROTEIN; PROTEIN BINDING; RAB3GAP1 PROTEIN, HUMAN; VAPB PROTEIN, HUMAN; VESICULAR TRANSPORT PROTEIN;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL NUCLEUS MEMBRANE; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GOLGI MEMBRANE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; NONHUMAN; POINT MUTATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; TWO HYBRID SYSTEM; ANIMAL; BINDING SITE; GENETICS; GOLGI COMPLEX; METABOLISM; MUTATION; PHYSIOLOGY; PROTEIN TRANSPORT; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; CARRIER PROTEINS; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; HUMANS; MUTATION; NUCLEAR ENVELOPE; PHENYLALANINE; PROTEIN BINDING; PROTEIN TRANSPORT; RAB3 GTP-BINDING PROTEINS; RATS; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TWO-HYBRID SYSTEM TECHNIQUES; VESICULAR TRANSPORT PROTEINS;

EID: 84907651956     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Aliaga, L., Lai, C., Yu, J., Chub, N., Shim, H., Sun, L., Xie, C., Yang, W.J., Lin, X., O'Donovan, M.J., and Cai, H. 2013. Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons. Hum Mol Genet 22: 4293-4305.
2. Chen, H.J., Anagnostou, G., Chai, A., Withers, J., Morris, A., Adhikaree, J., Pennetta, G., and de Belleroche, J.S. 2010. Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. J Biol Chem 285: 40266-40281.
3. Chen, Y.A., and Scheller, R.H. 2001. SNARE-mediated membrane fusion. Nat Rev Mol Cell Biol 2: 98-106.
4. Fasana, E., Fossati, M., Ruggiano, A., Brambillasca, S., Hoogenraad, C.C., Navone, F., Francolini, M., and Borgese, N. 2010. A VAPB mutant linked to amyotrophic lateral sclerosis generates a novel form of organized smooth endoplasmic reticulum. FASEB J 24: 1419-1430.
5. Fukui, K., Sasaki, T., Imazumi, K., Matsuura, Y., Nakanishi, H., and Takai, Y. 1997. Isolation and characterization of a GTPase activating protein specific for the Rab3 subfamily of small G proteins. J Biol Chem 272: 655-4658.
6. Haines, D.S., Lee, J.E., Beauparlant, S.L., Kyle, D.B., den Besten, W., Sweredoski, M.J., Graham, R.M., Hess, S., and Deshaies, R.J. 2012. Protein interaction profiling of the p97 adaptor UBXD1 points to a role for the complex in modulating ERGIC-53 trafficking. Mol Cell Proteomics 11: M111.016444.
7. Hanada, K. 2014. Co-evolution of sphingomyelin and the ceramide transport protein CERT. Biochim Biophys Acta 1841: 704-719.
8. Jahn, R., and Fasshauer, D. 2012. Molecular machines governing exocytosis of synaptic vesicles. Nature 490: 201-207.
9. Kaiser, S.E., Brickner, J.H., Reilein, A.R., Fenn, T.D., Walter, P., and Brunger, A.T. 2005. Structural basis of FFAT motif-mediated ER targeting. Structure 13: 1035-1045.
10. Kanekura, K., Nishimoto, I., Aiso, S., and Matsuoka, M. 2006. Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8). J Biol Chem 281: 30223-30233.
11. Kim, S., Leal, S.S., Ben Halevy, D., Gomes, C.M., and Lev, S. 2010. Structural requirements for VAP-B oligomerization and their implication in amyotrophic lateral sclerosis-associated VAP-B(P56S) neurotoxicity. J Biol Chem 285: 13839-13849.
12. Kuijpers, M., van Dis, V., Haasdijk, E.D., Harterink, M., Vocking, K., Post, J.A., Scheper, W., Hoogenraad, C.C., and Jaarsma, D. 2013. Amyotrophic lateral sclerosis (ALS)-associated VAPB-P56S inclusions represent an ER quality control compartment. Acta Neuropathol Commun 1: 24.
13. Lev, S., Ben Halevy, D., Peretti, D., and Dahan, N. 2008. The VAP protein family: from cellular functions to motor neuron disease. Trends Cell Biol 18:282–290.
14. Loewen, C.J., Roy, A., and Levine, T.P. 2003. A conserved ER targeting motif in three families of lipid binding proteins and in Opi1p binds VAP. EMBO J 22: 2025–2035.
15. Mesmin, B., Bigay, J., Moser von Filseck, J., Lacas-Gervais, S., Drin, G., and Antonny, B. 2013. A four-step cycle driven by PI(4)P hydrolysis directs sterol/PI(4)P exchange by the ER-Golgi tether OSBP. Cell 155: 830-843.
16. Mikitova, V., and Levine, T.P. 2012. Analysis of the key elements of FFAT-like motifs identifies new proteins that potentially bind VAP on the ER, including two AKAPs and FAPP2. PLoS One 7: e30455.
17. Nagano, F., Sasaki, T., Fukui, K., Asakura, T., Imazumi, K., and Takai, Y. 1998. Molecular cloning and characterization of the noncatalytic subunit of the Rab3 subfamily-specific GTPase-activating protein. J Biol Chem 273: 24781-24785.
18. Nishimura, A.L., Mitne-Neto, M., Silva, H.C., Richieri-Costa, A., Middleton, S., Cascio, D., Kok, F., Oliveira, J.R., Gillingwater, T., Webb, J., Skehel, P., and Zatz, M. 2004. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 75: 822-831.
19. Nishimura, Y., Hayashi, M., Inada, H., and Tanaka, T. 1999. Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins. Biochem Biophys Res Commun 254: 21–26.
20. Ooshio, T., Irie, K., Morimoto, K., Fukuhara, A., Imai, T., and Y. Takai, Y. 2004. Involvement of LMO7 in the association of two cell-cell adhesion molecules, nectin and E-cadherin, through afadin and alpha-actinin in epithelial cells. J Biol Chem 279: 31365-31373.
21. Prosser, D.C., Tran, D., Gougeon, P.Y., Verly, C., and Ngsee, J.K. 2008. FFAT rescues VAPA-mediated inhibition of ER-to-Golgi transport and VAPB-mediated ER aggregation. J Cell Sci 121: 3052-3061.
22. Raychaudhuri, S., and Prinz, W.A. 2010. The diverse functions of oxysterol-binding proteins. Annu Rev Cell Dev Biol 26: 157-177.
23. Rocha, N., Kuijl, C., van der Kant, R., Janssen, L., Houben, D., Janssen, H., Zwart, W., and Neefjes, J. 2009. Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 Glued and late endosome positioning. J Cell Biol 185: 1209-1225.
24. Saita, S., Shirane, M., Natume, T., Iemura, S., and Nakayama, K.I. 2009. Promotion of neurite extension by protrudin requires its interaction with vesicle-associated membrane protein-associated protein. J Biol Chem 284: 13766-13777.
25. Sakane, A., Manabe, S., Ishizaki, H., Tanaka-Okamoto, M., Kiyokage, E., Toida, K., Yoshida, T., Miyoshi, J., Kamiya, H., Takai, Y., and Sasaki, T. 2006. Rab3 GTPase-activating protein regulates synaptic transmission and plasticity through the inactivation of Rab3. Proc Natl Acad Sci USA 103: 10029-10034.
26. Skehel, P.A., Fabian-Fine, R., and Kandel, E.R. 2000. Mouse VAP33 is associated with the endoplasmic reticulum and microtubules. Proc Natl Acad Sci USA 97: 1101–1106
27. Skehel, P.A., Martin, K.C., Kandel, E.R., and Bartsch, D. 1995. A VAMP-binding protein from Aplysia required for neurotransmitter release. Science 269: 1580–1583.
28. Suzuki, H., Kanekura, K., Levine, T.P., Kohno, K., Olkkonen, V.M., Aiso, S., and Matsuoka, M. 2009. ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. J Neurochem 108: 973-985.
29. Teuling, E., Ahmed, S., Haasdijk, E., Demmers, J., Steinmetz, M.O., Akhmanova, A., Jaarsma, D., and Hoogenraad, C.C. 2007. Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J Neurosci 27: 9801-9815.
30. Tran, D., Chalhoub, A., Schooley, A., Zhang, W., and Ngsee, J.K. 2012. A mutation in VAPB that causes amyotrophic lateral sclerosis also causes a nuclear envelope defect. J Cell Sci 125:2831-2836.
31. Tuuf, J., Wistbacka, L., and Mattjus, P. 2009. The glycolipid transfer protein interacts with the vesicle-associated membrane protein-associated protein VAP-A. Biochem Biophys Res Commun 388: 395-399.
32. Weir, M.L., Klip, A., and Trimble, W.S. 1998. Identification of a human homologue of the vesicle-associated membrane protein (VAMP)-associated protein of 33 kDa (VAP-33): a broadly expressed protein that binds to VAMP. Biochem J 333: 247–251.
33. Wyles, J.P., and Ridgway, N.D. 2004. VAMP-associated protein-A regulates partitioning of oxysterol-binding protein-related protein-9 between the endoplasmic reticulum and Golgi apparatus. Exp Cell Res 297: 533-547.